Felber W, König L
Neurologisch-Psychiatrische Klinik der Medizinischen Akademie Carl Gustav Carus Dresden.
Psychiatr Prax. 1988 Mar;15(2):57-61.
Basing on 172 clinically recorded goitres among 787 patients treated with lithium (21.9%) we studied the question as to whether goitre formation due to lithium has any relevance within the concept of relapse prevention in affective disorders. A statistical comparison of essential disease parameters between the group of patients suffering from struma (goitre) and the total group shows that there is no special type or course of affective disorder with a particular affinity to the development of struma. Likewise, we can conclude from a comparison of treatment course and effectively parameters between both groups that development of struma under influence on the course of treatment or on the efficiency of prophylaxis. The results point to an irrelevance of lithium goitre in respect of psychiatric effects (this does not imply that it is irrelevant in respect of general medical aspects or endocrinology).
基于787例接受锂治疗的患者中有172例临床记录的甲状腺肿(21.9%),我们研究了锂导致的甲状腺肿形成在情感障碍复发预防概念中是否有任何关联这一问题。患有甲状腺肿(甲状腺肿大)的患者组与总患者组之间基本疾病参数的统计比较表明,不存在对甲状腺肿发展具有特殊亲和力的特定类型或病程的情感障碍。同样,通过两组之间治疗过程和有效参数的比较,我们可以得出结论,甲状腺肿的发展对治疗过程或预防效果没有影响。结果表明锂性甲状腺肿在精神方面无关紧要(这并不意味着它在一般医学方面或内分泌学方面无关紧要)。